As on Wednesday, Cellebrite DI Ltd (NASDAQ: CLBT) started slowly as it slid -0.95% to $16.62, before settling in for the price of $16.78 at the close. Taking a more long-term approach, CLBT posted a 52-week range of $6.36-$16.89.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Technology sector firm’s twelve-monthly sales growth has been 18.79% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is 51.67%. This publicly-traded company’s shares outstanding now amounts to $203.23 million, simultaneously with a float of $61.22 million. The organization now has a market capitalization sitting at $3.41 billion. At the time of writing, stock’s 50-day Moving Average stood at $12.94, while the 200-day Moving Average is $10.68.
Cellebrite DI Ltd (CLBT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Software – Infrastructure industry. Cellebrite DI Ltd’s current insider ownership accounts for 70.18%, in contrast to 33.94% institutional ownership.
Cellebrite DI Ltd (CLBT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
Cellebrite DI Ltd’s EPS increase for this current 12-month fiscal period is 51.67% and is forecasted to reach 0.30 in the upcoming year.
Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators
Let’s observe the current performance indicators for Cellebrite DI Ltd (CLBT). It’s Quick Ratio in the last reported quarter now stands at 1.69. The Stock has managed to achieve an average true range (ATR) of 0.70. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.41. Similarly, its price to free cash flow for trailing twelve months is now 37.64.
In the same vein, CLBT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.53, a figure that is expected to reach 0.08 in the next quarter, and analysts are predicting that it will be 0.30 at the market close of one year from today.
Technical Analysis of Cellebrite DI Ltd (CLBT)
Through scrutinizing the latest numbers posted by the [Cellebrite DI Ltd, CLBT], it can be observed that its last 5-days Average volume of 3.16 million was better the volume of 1.14 million, it posted the year before. During the previous 9 days, stock’s Stochastic%D was recorded 91.83% While, its Average True Range was 0.78.
Raw Stochastic average of Cellebrite DI Ltd (CLBT) in the period of the previous 100 days is set at 94.44%, which indicates a major rise in contrast to 92.64% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 56.95% that was higher than 40.65% volatility it exhibited in the past 100-days period.
